Our Studies
Filter by Site:
Penticton - Reduction of Major Adverse Cardiovascular Events
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.
Penticton - CVRR Outcome
North Shore - CVRR Outcome
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure.
Kelowna - CVRR Outcome
North Vancouver - Reduction of Major Adverse Cardiovascular Events
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart attack or stroke.
North Shore - Major Depressive Disorder
Kelowna - Difficult to Control COPD with Eosinophilic Phenotype
Kamloops – Eosinophilic Asthma
Is asthma making it hard to catch your breath? If you have eosinophilic asthma and are currently receiving medical care for your asthma, you could be eligible to participate in this clinical trial.
Kelowna - High Risk Asthma
Is asthma preventing you from breathing easy? If you are diagnosed with asthma and it makes it harder for you to breathe, you could be eligible to participate in this clinical trial.
West Vancouver – Asthma
Is asthma preventing you from breathing easy? If you are diagnosed with asthma and it makes it harder for you to breathe, you could be eligible to participate in this clinical trial.
Kelowna - Uncontrolled Asthma
